+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Premature Ejaculation Treatment Market by Drug Type (Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors), Type (Oral Therapies, Topical Therapies), Dosage Form, Distribution Channel - Forecast 2023-2030- Product Image
Global Premature Ejaculation Treatment Market by Drug Type (Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors), Type (Oral Therapies, Topical Therapies), Dosage Form, Distribution Channel - Forecast 2023-2030- Product Image
Sale

Global Premature Ejaculation Treatment Market by Drug Type (Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors), Type (Oral Therapies, Topical Therapies), Dosage Form, Distribution Channel - Forecast 2023-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2023
  • Region: Global
  • 360iResearch™
  • ID: 4968711
UP TO OFF until Dec 31st 2023
1h Free Analyst Time
Description Jump to:

Quick Summary:

In the dynamic landscape of the Premature Ejaculation Treatment Market, business leaders are constantly navigating through a variety of treatment options and evolving customer preferences. A comprehensive understanding of market trends, emerging segments, and competitive positioning is crucial for making informed strategic decisions. This report offers a 360-degree panorama of the market, with nuanced insights across drug types, therapies, dosage forms, and distribution channels, tailored to guide key stakeholders in carving out a successful path forward.

Armed with granular analysis and foresight, this market research report is a vital asset for executives seeking to capitalize on opportunities and tackle challenges in the Premature Ejaculation Treatment arena. Coverage of diverse regions reflects the global scope of the market, providing a multi-faceted viewpoint on potential growth areas. Furthermore, the FPNV Positioning Matrix and Market Share Analysis enhance the depth of strategic planning, ensuring that decisions are backed by robust data and a thorough analysis of vendor landscapes. This report masterfully aligns business intelligence with operational excellence, making it an indispensable guide in your market dominance journey.

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Premature Ejaculation Treatment Market size was estimated at USD 3.21 billion in 2022, USD 3.52 billion in 2023, growing at a CAGR of 9.78% to reach USD 6.77 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Premature Ejaculation Treatment Market.
  • Based on Drug Type, the market is studied across Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors, Topical Anesthetics, and Zertane. The Zertane is projected to witness significant market share during forecast period.
  • Based on Type, the market is studied across Oral Therapies and Topical Therapies. The Oral Therapies is is further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor. The Oral Therapies is projected to witness significant market share during forecast period.
  • Based on Dosage Form, the market is studied across Pills and Spray. The Pills is projected to witness significant market share during forecast period.
  • Based on Distribution Channel, the market is studied across Hospitals, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Premature Ejaculation Treatment Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Premature Ejaculation Treatment Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Premature Ejaculation Treatment Market, highlighting leading vendors and their innovative profiles. These include Ampio Pharmaceuticals, Inc., Aytu BioPharma, Inc., Bayer AG, Donga Pharmaceutical Co.,Ltd., Eli Lilly and Company, Emcure Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Hetero Healthcare Limited, Menarini Group, NeuroHealing Pharmaceuticals Inc., Pfizer Inc., Veru Inc., Wholesome Medtech Private Limited, and zr pharma& GmbH.

The report offers valuable insights on the following aspects:

  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast for the Premature Ejaculation Treatment Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Premature Ejaculation Treatment Market?
  3. What is the competitive strategic window for identifying opportunities in the Premature Ejaculation Treatment Market?
  4. What are the latest technology trends and regulatory frameworks in the Premature Ejaculation Treatment Market?
  5. What is the market share of the leading vendors in the Premature Ejaculation Treatment Market?
  6. Which modes and strategic moves are suitable for entering the Premature Ejaculation Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Frequently Asked Questions about the Global Premature Ejaculation Treatment Market

What is the estimated value of the Global Premature Ejaculation Treatment Market?

The Global Premature Ejaculation Treatment Market was estimated to be valued at $3.52 Billion in 2023.

What is the growth rate of the Global Premature Ejaculation Treatment Market?

The growth rate of the Global Premature Ejaculation Treatment Market is 9.7%, with an estimated value of $6.77 Billion by 2030.

What is the forecasted size of the Global Premature Ejaculation Treatment Market?

The Global Premature Ejaculation Treatment Market is estimated to be worth $6.77 Billion by 2030.

Who are the key companies in the Global Premature Ejaculation Treatment Market?

Key companies in the Global Premature Ejaculation Treatment Market include Ampio Pharmaceuticals, Inc., Aytu BioPharma, Inc., Bayer AG, Donga Pharmaceutical Co.,Ltd., Eli Lilly and Company, Emcure Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Hetero Healthcare Limited and Menarini Group.
Report AttributeDetails
No. of Pages199
PublishedOctober 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3.52 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.77 Billion
Compound Annual Growth Rate9.7%
Regions CoveredGlobal
No. of Companies Mentioned15

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Premature Ejaculation Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Raising governments awareness of premature ejaculation
5.1.1.2. Increasing prevalence of premature ejaculation
5.1.1.3. Availability of treatment through telehealth
5.1.2. Restraints
5.1.2.1. Side effects associated with the premature ejaculation treatment
5.1.3. Opportunities
5.1.3.1. Rising research & development of drugs for treatment
5.1.3.2. Increasing strategic collaborations for development of new diagnostic tools
5.1.4. Challenges
5.1.4.1. Shortage of medical professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Premature Ejaculation Treatment Market, by Drug Type
6.1. Introduction
6.2. Dapoxetine
6.3. Phosphodiesterase Type 5 (PDE5) Inhibitors
6.4. Selective Serotonin Reuptake Inhibitors
6.5. Topical Anesthetics
6.6. Zertane
7. Premature Ejaculation Treatment Market, by Type
7.1. Introduction
7.2. Oral Therapies
7.3.1. Nonselective Serotonin Reuptake Inhibitor
7.3.2. Selective Serotonin Reuptake Inhibitor
7.3. Topical Therapies
8. Premature Ejaculation Treatment Market, by Dosage Form
8.1. Introduction
8.2. Pills
8.3. Spray
9. Premature Ejaculation Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Premature Ejaculation Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Premature Ejaculation Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Premature Ejaculation Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Ampio Pharmaceuticals, Inc.
14.1.2. Aytu BioPharma, Inc.
14.1.3. Bayer AG
14.1.4. Donga Pharmaceutical Co.,Ltd.
14.1.5. Eli Lilly and Company
14.1.6. Emcure Pharmaceuticals
14.1.7. Futura Medical PLC
14.1.8. GlaxoSmithKline PLC
14.1.9. Hetero Healthcare Limited
14.1.10. Menarini Group
14.1.11. NeuroHealing Pharmaceuticals Inc.
14.1.12. Pfizer Inc.
14.1.13. Veru Inc.
14.1.14. Wholesome Medtech Private Limited
14.1.15. zr pharma& GmbH
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. PREMATURE EJACULATION TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PREMATURE EJACULATION TREATMENT MARKET DYNAMICS
FIGURE 7. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
FIGURE 8. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
FIGURE 12. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 14. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. PREMATURE EJACULATION TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 6. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 14. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 18. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 43. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 70. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 75. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 76. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 161. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 162. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 181. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 182. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 186. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 187. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 234. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 235. PREMATURE EJACULATION TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

  • Ampio Pharmaceuticals, Inc.
  • Aytu BioPharma, Inc.
  • Bayer AG
  • Donga Pharmaceutical Co.,Ltd.
  • Eli Lilly and Company
  • Emcure Pharmaceuticals
  • Futura Medical PLC
  • GlaxoSmithKline PLC
  • Hetero Healthcare Limited
  • Menarini Group
  • NeuroHealing Pharmaceuticals Inc.
  • Pfizer Inc.
  • Veru Inc.
  • Wholesome Medtech Private Limited
  • zr pharma& GmbH

Methodology

Loading
LOADING...

Related Topics

Related Reports

Premature Ejaculation Treatment - Global Strategic Business Report - Product Image

Premature Ejaculation Treatment - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Premature Ejaculation Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Premature Ejaculation Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
Global Premature Ejaculation Treatment Market 2024-2028 - Product Image

Global Premature Ejaculation Treatment Market 2024-2028

  • Report
  • 167 Pages
  • Global
From
CAS 129938-20-1 Dapoxetine hydrochloride Chemical World Database - Product Image

CAS 129938-20-1 Dapoxetine hydrochloride Chemical World Database

  • Database
  • Global
CAS 119356-77-3 Dapoxetine hydrochloride Chemical World Database - Product Image

CAS 119356-77-3 Dapoxetine hydrochloride Chemical World Database

  • Database
  • Global
Copyright © 2002-2023 Research and Markets. All Rights Reserved.